We just increased our Investment in ALA - Here’s why
Next Investors Feb 02, 2023
A few weeks ago, a child in the UK received a “base edited” cell therapy for leukaemia. The child went into remission (was cured) within four weeks. We also have an investment in the cell therapy space Arovella Therapeutics (ASX:ALA), that could be cheaper, more readily available, and more effective than existing cell therapy treatments.